Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 September 2023 | Story Supplied

The University of the Free State is pleased to present the second Bram Fischer Memorial Lecture, which will be delivered by award-winning biographer and professor of English literature, Stephen Clingman. Well-known author and advocate Tembeka Ngcukaitobi will respond. 

The lecture, titled Bram Fischer, Or What Happens When the World Becomes Inhospitable, will consider the continuing importance of Bram Fischer in a South African and global context. Bram Fischer was born in Bloemfontein in 1908 into one of the most prominent of Afrikaner families. While never surrendering his Afrikaner identity, he also transformed it by identifying with the struggle for liberation of all South Africa’s peoples. Sentenced to life imprisonment, he faced an inhospitable world, yet his commitment was to make the world more hospitable to all. 

Date: Wednesday 11 October 2023
Time: 18:00 to 21:00
Venue: Equitas Auditorium, Bloemfontein Campus, UFS

RSVP here to attend this lecture by 6 October 2023.

For further information, contact Alicia Pienaar at pienaaran1@ufs.ac.za.

The Speaker

Stephen Clingman is Distinguished University Professor of English and former Director of the Interdisciplinary Studies Institute at the University of Massachusetts Amherst. He has held several fellowships internationally and written widely on a range of topics. His books include The Novels of Nadine Gordimer: History from the Inside, The Grammar of Identity: Transnational Fiction and the Nature of the Boundary, Birthmark (a memoir/autofiction), and William Kentridge (the catalogue of Kentridge’s exhibition at the Royal Academy of Arts, 2022). His biography, Bram Fischer: Afrikaner Revolutionary, was co-winner of the Sunday Times Alan Paton Award, South Africa’s premier prize for non-fiction.

The Respondent

Tembeka Ngcukaitobi is a South African lawyer, public speaker, author, and political activist. He is a member of the South African Law Reform Commission. Ngcukaitobi has authored the books The Land Is Ours: South Africa's First Black Lawyers and the birth of Constitutionalism and Land Matters: South Africa's failed land reforms and the road ahead.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept